The Bariatric surgeries market size is projected to reach US$ 27,647.38 million by 2030 from US$ 8,546.66 million in 2023. The market is expected to register a CAGR of 15.8% during 2022–2030. Technological advancement such as robotics, advanced endoscopic suturing systems and others are likely to remain key trends in the market.
The increasing prevalence of obesity among large population owing to various lifestyle factors along with surging demand for minimally invasive procedures are driving the growth of bariatric surgeries market. Additionally, increasing awareness about weight loss and rising inclination towards healthy lifestyle has among large population along woth surge in R&D and producrt innovation is expected to anticipate the groeth of bariatric surgeries market. Moreover, increasing product launches for bariatric surgeries are expected to create ample opportunities in the coming years.
The major factors driving the growth of bariatric surgeries market are increasing prevalence of obesity among large population owing to various lifestyle factors along with surging demand for minimally invasive procedures. North Anerica dominated the market growth in terms of market share owing to the increasing obesity, rising product approvals, growing awareness about bariatric surgeries, and rising number of mergers, collaborations, and partnerships among the operating players. In addition, significantly growing incidences of obesity associated comorbidity are among the other leading factors escalating the demand for bariatric surgeries. However, Asia Pacific anticipated to register significant growth due to the collaborations among market players, increasing prevalence of obesity, and growing demand for minimally invasive surgeries in the region.
The positive outcomes of minimally invasive surgeries have increased the inclination toward minimally invasive bariatric surgeries as market players are focused on development and launch of advanced products. Nowadays, several minimally invasive bariatric surgeries are performed, including laparoscopic gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic gastric binding. As per the National Health Institutes 2022 report, nowadays, ~90% of gastric bypasses are done laparoscopically, with a death rate of 0.22%, which is less than 0.82% for open surgery. Each procedure has its own advantages and disadvantages, and the choice will depend upon the medical history and patient needs. Moreover, the rising inclination toward non-invasive bariatric devices is expected to proliferate the market growth. There are various manufacturers focused on the development of gastric balloons, which can be placed into the stomach through endoscopy procedures and can be easily removed when required. These balloons have limited to no side effects with positive outcomes. Therefore, the surge in minimally invasive bariatric surgeries, the launch and development of specialized instruments, and positive patient outcomes contribute to the growth of the bariatric surgeries market.
There has been a constant increase in the prevalence of obesity on a global level that has increased the demand for bariatric surgery devices. Various market players are also focused on product launches or strategic collaborations for the development of advanced products that help during bariatric surgeries and provide positive outcomes. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. For instance, In May 2023, Olympus launched POWERSEALTM Sealer/Divider for the Middle East and Africa (MEA) and Europe. This multifunctional advanced bipolar device supports surgeons across multiple different medical specialties with dissection, state-of-the-art sealing, and grasping capabilities for both open and laparoscopic surgical treatments such as colorectal resection, bariatric surgery, colorectal resection, and total laparoscopic hysterectomy. Additionally, In November 2022, Boston Scientific Corporation acquired Apollo Endosurgery Inc. with a total value of approximately US$ 615 million, which indicated a cash price of US$ 10 per share. The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close and manage gastrointestinal defects and complications, along with aid in weight loss for patients with obesity.
Key segments that contributed to the derivation of the Bariatric surgeries market analysis are type and end user.
The geographic scope of the Bariatric surgeries market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market owing to the increasing obesity, rising product approvals, growing awareness about bariatric surgeries, and rising number of mergers, collaborations, and partnerships among the operating players. In addition, significantly growing incidences of obesity associated comorbidity are among the other leading factors escalating the demand for bariatric surgeries. The US held the major share in North America region due to the increasing burden of obesity and growing prevalence of diabetes. Demand for bariatric surgeries has increased remarkably over the past few years to reduce burden of associated a wide range of chronic diseases. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.
The regional trends and factors influencing the Bariatric Surgeries Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Bariatric Surgeries Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 8,546.66 Million |
Market Size by 2030 | US$ 27,647.38 Million |
Global CAGR (2022 - 2030) | 15.8% |
Historical Data | 2020-2021 |
Forecast period | 2023-2030 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The Bariatric Surgeries Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Bariatric Surgeries Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Bariatric surgeries market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the Bariatric surgeries market are listed below:
The “Bariatric Surgeries Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
The List of Companies - Bariatric Surgery Devices Market
The estimated value of the Bariatric surgeries market by 2030 is US$ 27,647.38 million
The expected CAGR of the Bariatric surgeries market is 15.8%
North America region dominated the Bariatric surgeries market in 2022
The increasing prevalence of obesity among large population owing to various lifestyle factors along with surging demand for minimally invasive procedures are the driving factors impacting the Bariatric surgeries market
Technological advancement such as robotics, advanced endoscopic suturing systems and others are the future trends of the Bariatric surgeries market
The leading players operating in the Bariatric surgeries market Intuitive Surgicals Inc, Integra Lifesciences Holdings Corp, Apollo Endosurgery Inc., Conmed Corp, Medtronic Plc, Ethicon USA LLC, Olympus Corp, Reshape Lifesciences Inc, Spartz FGIA Inc among others